可诱导斑马鱼血小板减少模型用于药物筛选并揭示FGF信号调控血小板再生
研究构建Tg(cd41:eGFP-NTR)斑马鱼模型,用ronidazole诱导血小板特异性清除,模拟血小板减少症特征。筛选132种化合物发现3个候选物,其中tasisulam通过ERK信号促进血小板恢复,并在化疗诱导和先天性无巨核细胞血小板减少症模型及人Meg-01细胞中验证。
要点
- Tg(cd41:eGFP-NTR)斑马鱼模型可快速、特异清除血小板并观察动态恢复。
- 筛选132种化合物发现3个加速恢复候选物,tasisulam经ERK通路起效。
- tasisulam和4-甲基邻苯二酚在人Meg-01细胞中促进血小板生成,提示跨物种保守。
核心结论
- Tg(cd41:eGFP-NTR)斑马鱼模型为研究血小板减少症发病和体内恢复动态提供高时空分辨率平台。
- 成纤维细胞生长因子信号是血小板恢复的关键调控通路。
研究设计与样本
- 研究构建Tg(cd41:eGFP-NTR)斑马鱼模型,用ronidazole诱导血小板消融,并通过成像、表型分析和转录组学表征。
- 筛选132种化合物的靶向库,并在化疗诱导血小板减少症和先天性无巨核细胞血小板减少症斑马鱼模型及人Meg-01细胞中验证命中物。
主要发现
- Ronidazole处理通过细胞自主凋亡和巨噬细胞介导清除导致血小板快速、特异性耗竭,引起出血症状和血栓形成减少。
- 转录组分析和功能研究表明成纤维细胞生长因子信号在血小板恢复中起关键作用。
- 化合物库筛选鉴定出3个显著加速恢复的新候选物。
- Tasisulam通过细胞外信号调节激酶信号通路驱动血小板恢复,有效挽救化疗诱导和先天性无巨核细胞血小板减少症表型。
- Tasisulam和4-甲基邻苯二酚均促进人Meg-01细胞血小板生成,提示跨物种保守。
关键数值与推荐
- 靶向化合物库共筛选132种化合物。
- 鉴定出3个显著加速血小板恢复的新候选物。
临床怎么用
- 该模型可用于研究血小板减少症发病机制和体内恢复动态。
- 该平台可用于筛选具有跨物种疗效的治疗药物并揭示调控血小板再生的关键机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thrombocytopenia is a serious hematological disorder characterized by low platelet counts, with platelet recovery rate as a key prognostic factor. Current models have limitations, including acute toxicity, nonspecific cell ablation, and limited capacity to observe dynamic recovery. OBJECTIVES: This study aimed to establish a thrombocyte-specific ablation zebrafish model to study thrombocyte regeneration and screen for prorecovery compounds. METHODS: We generated a Tg(cd41:enhanced green fluorescent protein [eGFP]-nitroreductase [NTR]) zebrafish model to induce thrombocyte ablation using ronidazole. The model was characterized by imaging, phenotypic assays, and transcriptomics. A targeted library of 132 compounds was screened, and hits were validated in the chemotherapy-induced thrombocytopenia and congenital amegakaryocytic thrombocytopenia zebrafish models, as well as in human Meg-01 cells. RESULTS: Ronidazole treatment caused rapid, specific thrombocyte depletion through cell-autonomous apoptosis and macrophage-mediated clearance. This loss led to bleeding symptoms and reduced thrombus formation, resembling key features of thrombocytopenia. Transcriptomic analysis and functional studies showed that fibroblast growth factor signaling plays a critical role in thrombocyte recovery. Screening of the compound library identified 3 novel candidates that significantly accelerated recovery. Notably, tasisulam effectively rescued both chemotherapy-induced thrombocytopenia and congenital amegakaryocytic thrombocytopenia phenotypes by driving thrombocyte recovery via the extracellular signal-regulated kinase signaling pathway. In addition, both tasisulam and 4-methylcatechol promoted thrombopoiesis in human Meg-01 cells, indicating conservation across species. CONCLUSION: The Tg(cd41:eGFP-NTR) zebrafish model provides exceptional spatiotemporal resolution for investigating the pathogenesis and in vivo recovery dynamics of thrombocytopenia. It serves as a versatile platform for identifying therapeutic agents with cross-species efficacy and uncovering key mechanisms that regulate thrombocyte regeneration, revealing fibroblast growth factor signaling as a central regulator of thrombocyte recovery.
引用
- Deng J, Chen J, Wang Y, et al. An inducible zebrafish model of thrombocytopenia enables in vivo drug screening and reveals fibroblast growth factor signaling as a key regulator of platelet regeneration. J Thromb Haemost. 2026. PMID: 42705548. doi:10.1016/j.jtha.2026.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。